课题基金 / 基金详情

Targeted Inhibition of the FACT (Facilitates Chromatin Transcription) Complex as a Novel Therapeutic Approach in Aggressive Childhood Cancers

Targeted Inhibition of the FACT (Facilitates Chromatin Transcription) Complex as a Novel Therapeutic Approach in Aggressive Childhood Cancers
靶向抑制 FACT(促进染色质转录)复合物作为侵袭性儿童癌症的新型治疗方法
批准号:
nhmrc : 1085411
负责人:
A/Pr David Ziegler
金额:
$68.65万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2018-12-31

项目摘要

项目成果

A/Pr David Ziegler的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our research focusses on the most aggressive of all childhood cancers, and our aim is to develop novel therapies for these malignancies. We have discovered a new drug target called "FACT" in aggressive brain and solid tumours of childhood. Targeting FACT with a new class of drugs termed "curaxins" has a powerful anti-tumour effect. We aim to investigate the potential of these drugs as a new, effective therapy for incurable childhood cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determining the impacts of epigenetic modifying drugs on germline programming and offspring health
  • 批准号:
    nhmrc : GNT1144887
  • 项目类别:
    Project Grants
  • 资助金额:
    $86.39万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Ziegler
  • 依托单位:
Determining the impacts of epigenetic modifying drugs on germline programming and offspring health
  • 批准号:
    nhmrc : 1144887
  • 项目类别:
    Project Grants
  • 资助金额:
    $58.41万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Ziegler
  • 依托单位:
Optimising targeted polyamine depletion for treatment of childhood neuroblastoma and brain tumours
  • 批准号:
    nhmrc : GNT1125036
  • 项目类别:
    Project Grants
  • 资助金额:
    $92.82万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Ziegler
  • 依托单位:
Optimising targeted polyamine depletion for treatment of childhood neuroblastoma and brain tumours
  • 批准号:
    nhmrc : 1125036
  • 项目类别:
    Project Grants
  • 资助金额:
    $63.36万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Ziegler
  • 依托单位:
海外基金